Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

NCT01033552 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Epidermolysis Bullosa

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Anti-thymocyte globulin
DRUG: Myeloablative Busulfan
PROCEDURE: Mesenchymal stem cell transplantation
RADIATION: Total body irradiation
PROCEDURE: Bone marrow or umbilical cord blood (UCG) stem cell transplantation

Sponsor

Masonic Cancer Center, University of Minnesota